Drug intelligence / Profile preview

Lioliv-Biolik

Development stage
Unknown
Lead developer
Farmstandart-Biolik
Modality
Small Molecules
Administration
Intravenous
01

Overview

Lioliv-Biolik (often referred to as Liolif-Biolik) is a liposomal hepatoprotective combination drug developed and manufactured by Farmstandart-Biolik. It is formulated as a lyophilized powder for the preparation of an emulsion for intravenous injection. The drug contains two active ingredients: lecithin-standard (a source of essential phospholipids) and antral (aluminum anthranilate, a synthetic hepatoprotective agent). Lioliv-Biolik is indicated for the treatment of acute and chronic hepatitis of various etiologies (including viral hepatitis), benign hyperbilirubinemia, and liver cirrhosis in adults and children aged 12 years and older. It acts by inhibiting lipid peroxidation, stabilizing hepatocyte membranes, and promoting liver regeneration.

Brand names
Liolif-BiolikLiolivLioliv-Biolik
Other names
lecithin + aluminum anthranilatelecithin + antral

Beyond the preview

Go deeper on Lioliv-Biolik.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lioliv-Biolik.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call